Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer modelRoque Díaz(Universidad de Navarra), Alfonso Calvo(Instituto de Salud Carlos III)BMC CancerMay 11, 201010.1186/1471-2407-10-188Cited by 86SaveCiteExport RISWatch citationsRelated PapersThe C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma|Oncogene|2000|265Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies|Cancers|2021|76The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer|British Journal of Cancer|2009|53